Mucopolysaccharidosis Vii

Top drugs studied for this disease

EMA approval · 2026-07-08
EMA Authorised: Mepsevii (vestronidase alfa) — Ultragenyx Germany GmbH
EMA authorises Mepsevii (vestronidase alfa) for mucopolysaccharidosis VII in the EU.
EMA approval · 2024-06-28
EMA Authorised: Mepsevii (vestronidase alfa) — Ultragenyx Germany GmbH
The European Medicines Agency authorised Mepsevii (vestronidase alfa) from Ultragenyx Germany GmbH for mucopolysaccharidosis VII in the Euro…